<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1554">
 <bold>Conclusions:</bold> One century after phages discovery, Phagoburn is the first mutlicentric control randomized trial ever done in the world about phage therapy in humans. Results will be available in 2016. Phages could be an old but innovative way in the war against antimicrobial resistance. Antimicrobial resistance could be the leading cause of mortality in 2050.
</p>
